Gold prices steady ahead of Fed decision; weekly weakness noted
Christopher Nardecchia, Senior Vice President and Chief Information Officer at Rockwell Automation, Inc. (NYSE:ROK), executed a sale of 551 shares of common stock on June 9, 2025. The shares were sold at an average price of $326.3082, amounting to a total transaction value of $179,795. This sale was conducted under a Rule 10b5-1 plan, which was established on November 27, 2024, to cover taxes due on restricted stock units that vested on June 6, 2025. The transaction occurs as Rockwell Automation trades near its 52-week high of $328.90, with InvestingPro analysis indicating the stock is currently trading above its Fair Value.
Prior to this, Nardecchia acquired 1,552 shares of common stock on June 6, 2025, through the vesting of restricted stock units, at no cost. Post these transactions, Nardecchia holds 12,711 shares directly. Additionally, Nardecchia holds 5.5359 shares indirectly through a company savings plan. The $36.64B market cap company has demonstrated strong performance, with a 29.76% return over the past year. InvestingPro subscribers can access 13 additional key insights and a comprehensive Pro Research Report about Rockwell Automation’s valuation and growth prospects.
In other recent news, Rockwell Automation has been the subject of several analyst upgrades and strategic developments. Barclays (LON:BARC) analyst Julian Mitchell upgraded the company’s stock rating from Equal Weight to Overweight, raising the price target to $350, citing a firmer top-line outlook and the conclusion of a destocking period. KeyBanc Capital Markets also adjusted its outlook, increasing the price target to $345 while maintaining an Overweight rating, highlighting Rockwell Automation’s operational excellence and potential in the discrete manufacturing sector. Additionally, TD Cowen upgraded the stock from Sell to Hold, with a new price target of $275, recognizing effective cost control measures and order stabilization.
Oppenheimer raised its price target to $304 following Rockwell Automation’s strong margin performance and an updated fiscal year 2025 earnings per share forecast that surpassed market expectations. In terms of new product offerings, Rockwell Automation introduced FactoryTalk PharmaSuite 12.00, a manufacturing execution system designed for the pharmaceutical and biopharmaceutical sectors, featuring enhanced cybersecurity and modular architecture. This release is part of the company’s ongoing efforts to support digital transformation in regulated industries. Rockwell Automation’s strategic moves, including the opening of a new manufacturing facility in Milwaukee, underscore its commitment to strengthening its market position and supply chain capabilities. These recent developments highlight the company’s adaptive strategies and the optimistic outlook from various analyst firms.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.